Establishing the Median Infectious Dose (ID50) and Characterizing the Clinical Manifestations of Mouse, Rat, Cow, and Human Corynebacterium bovis Isolates in Select Immunocompromised Mouse Strains
G. Mendoza, C. Cheleuitte-Nieves, N. S. Lipman, J. R. K. Wipf, R. J. Ricart Arbona, I. C. Miranda, R. J. Ricart Arbona
This study determines the ID50 and clinical manifestations of Cb isolates from mice, rats, cows, and humans in immunocompromised mice, showing differences in infectivity and disease severity.
bioRxiv · Nov 10, 2022 · PreprintMicrobiology